A citation-based method for searching scientific literature

Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane Pinto, Robert P Giugliano, Matthew J Budoff, Jean-Claude Tardif, Subodh Verma, Christie M Ballantyne. Circulation 2021
Times Cited: 24







List of co-cited articles
1460 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Deepak L Bhatt, P Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. N Engl J Med 2019
87

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.
Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. J Am Coll Cardiol 2019
145
70

REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
Deepak L Bhatt, Michael Miller, Eliot A Brinton, Terry A Jacobson, Ph Gabriel Steg, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. Circulation 2020
66
50

Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
Matthew J Budoff, Deepak L Bhatt, April Kinninger, Suvasini Lakshmanan, Joseph B Muhlestein, Viet T Le, Heidi T May, Kashif Shaikh, Chandana Shekar, Sion K Roy,[...]. Eur Heart J 2020
126
45

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
Stephen J Nicholls, A Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M Ballantyne, Philip J Barter, Michael H Davidson, John J P Kastelein, Wolfgang Koenig, Darren K McGuire,[...]. JAMA 2020
221
45

Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.
R Preston Mason, Peter Libby, Deepak L Bhatt. Arterioscler Thromb Vasc Biol 2020
119
41

Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.
Deepak L Bhatt, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Michael Miller, Jean-Claude Tardif, Steven B Ketchum, Ralph T Doyle, Sabina A Murphy, Paresh N Soni,[...]. Clin Cardiol 2017
112
41

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki, Yuji Matsuzawa, Yasushi Saito, Yuichi Ishikawa, Shinichi Oikawa, Jun Sasaki, Hitoshi Hishida, Hiroshige Itakura,[...]. Lancet 2007
33

Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management.
Om P Ganda, Deepak L Bhatt, R Preston Mason, Michael Miller, William E Boden. J Am Coll Cardiol 2018
107
33

Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles.
Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Lixia Jiao, Jean-Claude Tardif, John Gregson, Stuart J Pocock, Christie M Ballantyne. J Am Coll Cardiol 2019
49
33

REDUCE-IT.
Deepak L Bhatt. Eur Heart J 2019
26
29

Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.
Louise Bowman, Marion Mafham, Karl Wallendszus, Will Stevens, Georgina Buck, Jill Barton, Kevin Murphy, Theingi Aung, Richard Haynes, Jolyon Cox,[...]. N Engl J Med 2018
326
29

Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.
Are Annesønn Kalstad, Peder Langeland Myhre, Kristian Laake, Sjur Hansen Tveit, Erik Berg Schmidt, Paal Smith, Dennis Winston Trygve Nilsen, Arnljot Tveit, Morten Wang Fagerland, Svein Solheim,[...]. Circulation 2021
77
29

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
Jackie Bosch, Hertzel C Gerstein, Gilles R Dagenais, Rafael Díaz, Leanne Dyal, Hyejung Jung, Aldo P Maggiono, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
593
29

The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction.
Xiaowen Wang, Subodh Verma, R Preston Mason, Deepak L Bhatt. Curr Diab Rep 2020
8
87

Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease.
Fabien Picard, Deepak L Bhatt, Grégory Ducrocq, Yedid Elbez, Roberto Ferrari, Ian Ford, Jean-Claude Tardif, Michal Tendera, Kim M Fox, Philippe Gabriel Steg. J Am Coll Cardiol 2019
26
25

Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
Matthew J Budoff, Joseph B Muhlestein, Deepak L Bhatt, Viet T Le Pa, Heidi T May, Kashif Shaikh, Chandana Shekar, April Kinninger, Suvasini Lakshmanan, Sion K Roy,[...]. Cardiovasc Res 2021
27
25

Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
JoAnn E Manson, Nancy R Cook, I-Min Lee, William Christen, Shari S Bassuk, Samia Mora, Heike Gibson, Christine M Albert, David Gordon, Trisha Copeland,[...]. N Engl J Med 2019
417
25

A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins.
Tetsu Watanabe, Kaoru Ando, Hyuma Daidoji, Yoichiro Otaki, Shigeo Sugawara, Motoyuki Matsui, Eiichiro Ikeno, Osamu Hirono, Hiroshi Miyawaki, Yoshinori Yashiro,[...]. J Cardiol 2017
81
25

REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results.
Brian Olshansky, Deepak L Bhatt, Michael Miller, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao,[...]. Eur Heart J Cardiovasc Pharmacother 2021
9
66

Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies.
Patrick R Lawler, Gynter Kotrri, Maria Koh, Shaun G Goodman, Michael E Farkouh, Douglas S Lee, Peter C Austin, Jacob A Udell, Dennis T Ko. Eur Heart J 2020
47
20

Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study).
Christie M Ballantyne, Harold E Bays, John J Kastelein, Evan Stein, Jonathan L Isaacsohn, Rene A Braeckman, Paresh N Soni. Am J Cardiol 2012
231
20


2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
20

n-3 fatty acids and cardiovascular events after myocardial infarction.
Daan Kromhout, Erik J Giltay, Johanna M Geleijnse. N Engl J Med 2010
631
20

A Revolution in Omega-3 Fatty Acid Research.
Deepak L Bhatt, Matthew J Budoff, R Preston Mason. J Am Coll Cardiol 2020
11
45

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Theingi Aung, Jim Halsey, Daan Kromhout, Hertzel C Gerstein, Roberto Marchioli, Luigi Tavazzi, Johanna M Geleijnse, Bernhard Rauch, Andrew Ness, Pilar Galan,[...]. JAMA Cardiol 2018
362
20

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
Luigi Tavazzi, Aldo P Maggioni, Roberto Marchioli, Simona Barlera, Maria Grazia Franzosi, Roberto Latini, Donata Lucci, Gian Luigi Nicolosi, Maurizio Porcu, Gianni Tognoni. Lancet 2008
893
20

Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
Suzanne V Arnold, Deepak L Bhatt, Gregory W Barsness, Alexis L Beatty, Prakash C Deedwania, Silvio E Inzucchi, Mikhail Kosiborod, Lawrence A Leiter, Kasia J Lipska, Jonathan D Newman,[...]. Circulation 2020
60
16

OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
Bernhard Rauch, Rudolf Schiele, Steffen Schneider, Frank Diller, Norbert Victor, Helmut Gohlke, Martin Gottwik, Gerhard Steinbeck, Ulrike Del Castillo, Rudolf Sack,[...]. Circulation 2010
386
16


EPA and DHA containing phospholipids have contrasting effects on membrane structure.
Samuel C R Sherratt, Rebecca A Juliano, Christina Copland, Deepak L Bhatt, Peter Libby, R Preston Mason. J Lipid Res 2021
7
57

Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability.
Samuel C R Sherratt, Hazem Dawoud, Deepak L Bhatt, Tadeusz Malinski, R Preston Mason. Prostaglandins Leukot Essent Fatty Acids 2021
10
40

Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis.
Safi U Khan, Ahmad N Lone, Muhammad Shahzeb Khan, Salim S Virani, Roger S Blumenthal, Khurram Nasir, Michael Miller, Erin D Michos, Christie M Ballantyne, William E Boden,[...]. EClinicalMedicine 2021
24
16


Applicability of the REDUCE-IT trial to the FAST-MI registry. Are the results of randomized trials relevant in routine clinical practice?
Jean Ferrières, Vincent Bataille, Etienne Puymirat, François Schiele, Tabassome Simon, Nicolas Danchin. Clin Cardiol 2020
7
57

Reply: Ischemic Event Reduction and Triglycerides.
Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Rebecca A Juliano, Christie M Ballantyne. J Am Coll Cardiol 2019
9
44

Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
Harold E Bays, Rene A Braeckman, Christie M Ballantyne, John J Kastelein, James D Otvos, William G Stirtan, Paresh N Soni. J Clin Lipidol 2012
54
16

Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
Prakriti Gaba, Deepak L Bhatt, Robert P Giugliano, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao,[...]. J Am Coll Cardiol 2021
9
44

2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.
Salim S Virani, Pamela B Morris, Anandita Agarwala, Christie M Ballantyne, Kim K Birtcher, Penny M Kris-Etherton, Amanda B Ladden-Stirling, Michael Miller, Carl E Orringer, Neil J Stone. J Am Coll Cardiol 2021
28
16

Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Subodh Verma, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Nitish K Dhingra, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao,[...]. Circulation 2021
8
50

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. J Am Coll Cardiol 2019
946
12


Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma.
Ryo Nishio, Toshiro Shinke, Hiromasa Otake, Masayuki Nakagawa, Ryoji Nagoshi, Takumi Inoue, Amane Kozuki, Hirotoshi Hariki, Tsuyoshi Osue, Yu Taniguchi,[...]. Atherosclerosis 2014
80
12

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes.
R Preston Mason, Robert F Jacob, Sandeep Shrivastava, Samuel C R Sherratt, Amitabha Chattopadhyay. Biochim Biophys Acta 2016
80
12


Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies.
Harold E Bays, Christie M Ballantyne, Rene A Braeckman, William G Stirtan, Paresh N Soni. Am J Cardiovasc Drugs 2013
95
12

Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin.
R Preston Mason, Hazem Dawoud, Robert F Jacob, Samuel C R Sherratt, Tadeusz Malinski. Biomed Pharmacother 2018
41
12




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.